[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100611172":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":17,"centralContacts":18,"locations":24,"responsibleParty":55,"collaborators":17,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":9,"officialTitle":61,"acronym":17,"eligibilityCriteria":62,"healthyVolunteers":59,"sex":63,"minAge":64,"maxAge":65,"enrollmentInfo":66,"targetDuration":17,"studyType":69,"phases":70,"briefSummary":72,"conditions":73,"keywords":75,"overallStatus":46,"whyStopped":17,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","OTHER",[8],{"label":9,"type":10,"description":9,"interventionNames":11},"Single-port Robotic Radical Gastrectomy for Gastric Cancer","EXPERIMENTAL",[12],"Procedure: Single-port Robotic Radical Gastrectomy for Gastric Cancer",[14],{"type":15,"name":9,"description":9,"armGroupLabels":16,"otherNames":17},"PROCEDURE",[9],null,[19],{"name":20,"role":21,"phone":22,"phoneExt":17,"email":23},"Fan Li MD","CONTACT","0008602368757350","Levinecq@163.com",[25,44],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"Daping Hospital","NOT_YET_RECRUITING","Chongqing","Chongqing Municipality","400042","China","CN",{"type":34,"coordinates":35},"Point",[36,37],106.55771,29.56026,{"lat":37,"lon":36},[40],{"name":41,"role":21,"phone":42,"phoneExt":17,"email":43},"Chuan Huang","86-13140290998","331998408@qq.com",{"facility":45,"status":46,"city":28,"state":17,"zip":17,"country":31,"countryCode":32,"cosmosGeoPoint":47,"geoPoint":49,"contacts":50},"Daping Hospital of Army Medical Universty","RECRUITING",{"type":34,"coordinates":48},[36,37],{"lat":37,"lon":36},[51],{"name":52,"role":21,"phone":53,"phoneExt":17,"email":54},"Chao Hui Zheng","8023-68729350","625730455@qq.com",{"type":56,"investigatorFullName":17,"investigatorTitle":17,"investigatorAffiliation":17,"oldNameTitle":17,"oldOrganization":17},"SPONSOR","100611172","single-port-robotic-radical-gastrectomy-for-gastric-cancer-100611172",false,"NCT07237126","Efficacy and Safety Assessment of Single-port Robotic Radical Gastrectomy for Gastric Cancer: a Phase 2a Trial Based on the IDEAL Framework","Inclusion Criteria:\n\n* (1) Age: 18-75 years; (2) Histologically confirmed gastric adenocarcinoma by endoscopic biopsy; (3) Preoperatively staged as either endoscopically unresectable T1, or cT2-4a with or without nodal involvement (N-\u002F+), and no distant metastasis (M0), according to the 7th edition of the AJCC Cancer Staging Manual; (4) Eligible for potentially curative surgical resection; (5) Eastern Cooperative Oncology Group (ECOG) performance status score of 0-1; (6) American Society of Anesthesiologists (ASA) physical status classification of I-III; (7) Provision of written informed consent.\n\nExclusion Criteria:\n\n* (1) Pregnant or lactating women; (2) Severe psychiatric disorder; (3) History of prior upper abdominal surgery; (4) Previous gastrectomy, endoscopic submucosal dissection (ESD), or endoscopic mucosal resection (EMR); (5) Preoperative imaging showing regional lymphadenopathy with lymph node(s) larger than 3 cm in diameter; (6) History of another primary malignancy within the past 5 years; (7) Prior neoadjuvant chemotherapy or radiotherapy; (8) History of cerebrovascular or cardiovascular event (e.g., stroke or myocardial infarction) within the past 6 months; (9) Systemic corticosteroid use for more than one month within the past month; (10) Requirement for concomitant surgery for other conditions; (11) Need for emergency surgery due to gastric cancer-related complications (e.g., bleeding, obstruction, or perforation); (12) Participation in another interventional clinical trial previously; (13) Active severe infectious disease; (14) Severe systemic disease.","ALL","18 Years","75 Years",{"count":67,"type":68},20,"ESTIMATED","INTERVENTIONAL",[71],"NA","This study is a single-center, phase 2a exploratory clinical study based on IDEAL framework. The intraoperative and postoperative complications were analyzed to evaluate the safety, feasibility and clinical efficacy of single-port robot-assisted gastric tumor resection.",[74],"Gastric Cancer Patients Undergoing Gastrectomy",[76,77,78],"Single-port robotic","Gastric cancer","Radical Gastrectomy","2026-08-02",{"date":81,"type":82},"2026-08-04","ACTUAL",{"date":84,"type":68},"2026-07-22",{"date":86,"type":68},"2027-12-31",{"name":5,"class":6},2]